Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,591 | 272,350 | 248,758 | 232,414 | 274,207 |
| Marketable Securities | 191,668 | 125,979 | 143,284 | 31,936 | 11,913 |
| Receivables | 1,187 | N/A | 1,127 | 508 | 3,511 |
| Inventories | 15,936 | 13,927 | 6,757 | N/A | N/A |
| TOTAL | $372,246 | $419,427 | $411,640 | $278,019 | $297,897 |
| Non-Current Assets | |||||
| PPE Net | 4,758 | 4,786 | 9,663 | 6,423 | 5,922 |
| Investments And Advances | 12,603 | 24,380 | 28,797 | 0 | 0 |
| Intangibles | 9,854 | 9,332 | 11,441 | 10,627 | 10,944 |
| Other Non-Current Assets | 17,617 | 5,736 | 209 | 209 | 209 |
| TOTAL | $44,832 | $44,234 | $50,110 | $17,259 | $17,075 |
| Total Assets | $417,078 | $463,661 | $461,750 | $295,278 | $314,972 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,694 | 24,797 | 20,189 | 13,641 | 12,411 |
| Other current liabilities | 2,382 | 6,412 | 3,582 | 3,384 | 1,649 |
| TOTAL | $21,151 | $31,997 | $23,889 | $17,143 | $14,178 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 118 | 118 | 118 |
| Other Non-Current Liabilities | 25,699 | 23,914 | 38,900 | 38,949 | 37,210 |
| TOTAL | $25,699 | $23,914 | $39,018 | $39,096 | $37,386 |
| Total Liabilities | $46,850 | $55,911 | $62,907 | $56,239 | $51,564 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 128,156 | N/A | N/A | N/A | N/A |
| Common Shares | 952,673 | 944,328 | 986,468 | 796,350 | 794,932 |
| Retained earnings | -625,535 | -575,156 | -619,930 | -585,866 | -556,340 |
| Other shareholders' equity | -799 | -805 | -805 | -805 | -805 |
| TOTAL | $370,228 | $407,750 | $398,843 | $239,039 | $263,408 |
| Total Liabilities And Equity | $417,078 | $463,661 | $461,750 | $295,278 | $314,972 |